13D Filings Reported
Disclosures are from 13Ds filed with the Securities and Exchange Commission, which are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
6 results loaded, newest first. End of these results.
Disclosures are from 13Ds filed with the Securities and Exchange Commission, which are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Sept…
13D disclosures were filed with the SEC within 10 days of crossing a 5% ownership threshold; amendments report subsequent changes in holdings or intentions.
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Sept…
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Aug…
Oruka Therapeutics Inc. (NASDAQ: ORKA ) shares fell in after-hours trading on Wednesday after SEC filings showed major shareholder Fairmount Healthcare Fund II sold a large block of shares worth about $300 million. ORKA closed Wednesday’s regular session at $93.29, down 1.98%. In after-hours trading, the stock fell to